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Di(2-ethylhexyl) phthalate (DEHP) is a chiral persistent organic pollutant that is 
used as a plasticizer in polyvinyl chloride (PVC). Humans are exposed to DEHP through 
inhalation, ingestion, and intravenous exposure; it has shown toxicity as an endocrine 
disrupter and carcinogen. In the body, DEHP is broken down into mono(2-ethylhexyl) 
phthalate (MEHP), which is subsequently oxidized in various locations on the ethylhexyl 
chain. Since previous studies of DEHP have ignored chirality, the purpose of this 
research is to synthesize enantiomerically pure oxidative metabolites of DEHP. One of 
the oxidative metabolites of DEHP, 2cx-MMHP, was produced by a malonic ester 
synthesis followed by lithium aluminum hydride (LAH) reduction, esterification with 
phthalic anhydride, and oxidation in 14% overall yield. A precursor to three of the other 
oxidative metabolites, mono(2-ethyl-5-hexenyl) phthalate, was prepared in an analogous 
manner, beginning with the alkylation of diethyl ethylmalonate with 4-iodo-1-butene, in 
34% yield. In future work, the terminal alkene of mono(2-ethyl-5-hexenyl) phthalate will 
be oxidized, yielding 5cx-MEPP, 5oxo-MEHP, and 5OH-MEHP. Then, a resolution step 
will be incorporated into both syntheses to produce both enantiomers of each metabolite. 
Enantiomerically pure oxidative metabolites of DEHP would serve as standards in 
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Persistent organic pollutants 
Persistent organic pollutants (POPs) are organic compounds that do not break 
down readily in the environment. Examples of POPs include pesticides such as 
organophosphorus compounds and pharmaceuticals. Many of these pollutants are chiral; 
even though a compound’s enantiomers have the same physical and chemical properties, 
their effect on biological processes can differ greatly. Enzymes and biological receptors 
are chiral and, therefore, interact differently with chiral compounds.1 For example, with 
chiral drugs, one enantiomer can have the desired effect while the other might have the 
opposite effect or cause unwanted side effects.2 An example of this was seen with 
thalidomide, which was used as a morning sickness drug in the 1950s. While the (R) 
enantiomer successfully alleviated nausea, the (S) enantiomer was teratogenic and caused 
birth defects in many children born at the time.3 Studies on chiral chemicals often 
disregard stereoisomers because chiral chemicals are most easily produced as racemic 
mixtures; therefore, current knowledge of chiral pollutants is incomplete.1 
Phthalates 
Phthalates are a common family of POPs.4, 5 They are industrial chemicals often 
used as plasticizers that are found in a plethora of household items including plastics, 
cosmetics, adhesives, and food products. Humans are exposed to phthalates in many 
ways. Ingestion of phthalates is possible through contaminated food or by children 
putting toys in their mouth, dermal exposure to phthalates occurs due to cosmetics 
containing phthalates, inhalation of phthalates can occur from nail polish or hair spray, 




the constant human exposure, concern about the health effects of phthalates is rising. 
They are suspected of being endocrine disrupters, meaning they affect the hormones that 
regulate developmental processes, adversely affecting reproductive development.4, 5 
Di(2-ethylhexyl) phthalate 
In particular, di(2-ethylhexyl) phthalate (DEHP), shown in Figure 1, is a racemic 
persistent organic pollutant (POP) that is widely used as a plasticizer in polyvinyl 
chloride (PVC). DEHP can be found in numerous products including children’s toys, 
vinyl flooring, detergents, wood finishes, food packaging,6, 7 and medical devices.7 
However, DEHP is not chemically bound to PVC, so it is able to leach out of plastics and 
into the environment.8, 9 This allows for human exposure to DEHP through inhalation, 
ingestion, and intravenous exposure.10 The general population is exposed to DEHP at a 
rate of 1.7-52.1 µg/kg/day.11, 12 
 
 
Figure 1: Di(2-ethylhexyl) pthalate (DEHP). The asterisks indicate the two 
stereocenters present in the molecule, and the wavy bonds denote that each 
stereocenter could be in either the (S) or the (R) configuration. 
 
DEHP, like other phthalates, has shown toxicity in animals and humans. As a 




functions.12, 13 It is an embryotoxin in mice,14 reproductive toxin in rodents,10 
developmental toxin in animals,9 and carcinogenic in rodents.15 Additionally, DEHP has 
been linked to anti-androgenic effects in male rats,16 decreased estradiol production and 
inhibited antral follicle growth in female mice,17, 18 and autism spectrum disorders in 
humans.19 Many adverse health effects of DEHP are thought to be linked to the 
interaction between DEHP metabolites and peroxisome proliferator-activated receptors 
(PPARs).10, 20 PPARs are a type of nuclear receptor proteins that regulate the expression 
of genes. In particular, PPARα regulates the uptake and metabolism of fatty acids, 
PPARβ/δ regulates fat oxidation, and PPARγ regulates lipid synthesis and storage.21, 22 
DEHP and its metabolites activate all three subtypes of PPAR, therefore altering lipid 
metabolism.21, 22  
The metabolism of DEHP in the human body is shown in Scheme 1. DEHP is first 
hydrolyzed to mono(2-ethylhexyl) phthalate (MEHP) and 2-ethylhexanol; this process is 
catalyzed by both esterases and lipases in the liver, intestines, and kidney.23, 24 MEHP is 
then oxidized by cytochrome P450 4A and alcohol dehydrogenase (ADH) or aldehyde 
dehydrogenase (ALDH) in the liver and intestines.24 
Some metabolites of DEHP have been previously synthesized and used as 
standards for biomonitoring studies.6 Such studies have shown the oxidative metabolites 
to be the most useful for biomonitoring, because they are more prevalent in urine than 
DEHP and MEHP.8, 9, 11 The four most abundant oxidative metabolites were found to be 
5OH-MEHP, 5cx-MEPP, 5oxo-MEHP, and 2cx-MMHP.11 Previous studies of DEHP and 
its metabolites, however, have neglected chirality. All of the metabolites of DEHP 




enantiomers/diasteriomers. It is beneficial to synthesize each enantiomer individually, 
since the enantiomers could have different effects on biochemical processes.2 
 
 
Scheme 1: Metabolism of DEHP. DEHP is first hydrolyzed to MEHP and  
2-ethyl-1-hexanol. MEHP is then oxidized in different positions on the  
2-ethylhexyl chain, as is indicated by the red bonds. 
 
Therefore, the purpose of this research is to synthesize enantiomerically pure oxidative 
metabolites of DEHP, focusing on 5OH-MEHP, 5cx-MEPP, 5oxo-MEHP, and 2cx-
MMHP. These synthesized metabolites would serve as standards in metabolism, 
biomonitoring, and toxicity studies. 
Proposed syntheses 




malonic ester synthesis of 2-allyl-hexanoic acid 3. In the alkylation step, diethyl 
allylmalonate is deprotonated by sodium hydride (NaH) at carbon 2. The resulting 
carbanion then nucleophilically attacks 1-iodobutane, producing diethyl 
allylbutylmalonate 1. 25 The next step is a base catalyzed hydrolysis in which both esters 
are converted to carboxylic acids.26, 27 Heating then leads to decarboxylation, producing 
2-allyl-hexanoic acid 3.26  
The carboxylic acid is reduced to an alcohol via lithium aluminum hydride (LAH) 
reduction, producing 2-allyl-1-hexanol 4.28, 29 An esterification reaction between 2-allyl-
1-hexanol and phthalic anhydride in which pyridine acts as a base produces mono(2-
allylhexyl) phthalate 5.6 
 
 





 The last step of this proposed synthesis is the ruthenium-catalyzed oxidative 
cleavage of the alkene to a carboxylic acid. The proposed mechanism of this reaction is 
shown in Scheme 3. After ruthenium tetroxide (RuO4) is produced from the reaction of 
Ru3+, IO4
-, and H2O, a complex is formed between the alkene and two of the RuO4 
oxygens. A ring-opening mechanism then leads to the formation of 2COH-MMHP and 




Scheme 3: Ruthenium-catalyzed oxidative cleavage of mono(2-allylhexyl) phthalate  
mechanism 
 
The proposed synthesis of 5OH-MEHP, 5cx-MEPP, and 5oxo-MEHP follows an 
analygous scheme, beginning with the alkylation of diethyl ethylmalonate with 4-iodo-1-
butene 7 to produce mono(2-ethyl-5-hexenyl) phthalate 12 (Scheme 4).  The terminal 








Scheme 4: Proposed synthesis of mono(2-ethyl-5-hexenyl) phthalate from diethyl  
ethylmalonate  
 
In this work, the oxidative metabolite 2cx-MMHP 6 and mono(2-ethyl-5-hexenyl) 
phthalate 12, a precursor to 5OH-MEHP, 5cx-MEPP, and 5oxo-MEHP, were synthesized 
racemically by a malonate ester synthesis, LAH reduction, esterification, and oxidation. 
As was outlined above, the ultimate goal is to produce both enantiomers of each 
metabolite. This will be done by oxidizing mono(2-ethyl-5-hexenyl) phthalate 12 and 







II. Results and Discussion 
Malonic ester synthesis of 2-allyl-hexanoic acid (3) 
 The synthesis of 2-allyl-hexanoic acid 3, which follows a traditional malonic ester 
synthesis, is shown in Scheme 5. The alkylation of diethyl allylmalonate was conducted 
via a procedure modified from the literature in which the synthesis of dimethyl 
allylmalonate from dimethyl malonate was conducted with 0.8 equivalents of both NaH 
and allyl bromide to avoid the dialkylation of dimethyl malonate.25 The dialkylation of 
diethyl allylmalonate is not possible because it is already monoalkylated, so an excess of 
NaH (1.2 equivalents) and 1-iodobutane (1.5 equivalents) was used in this synthesis. 
First, NaH was added to diethylallylmalonate in THF at 0°C and allowed to stir for half 
an hour to deprotonate the malonate. The subsequent addition of 1-iodobutane and 
stirring for 21 hours at room temperature allowed for the production of diethyl 









 The next step in the synthesis was the base hydrolysis of 1. Initially, a literature 
procedure was followed in which 2.2 equivalents of KOH and a 1:2 H2O/EtOH solvent 
were used.26 Four attempts at conducting this reaction at reflux overnight were proven 
unsuccessful by the existence of three new spots on the TLC plates of the crude products. 
Based on a different literature procedure, the reaction was conducted with 5 equivalents 
of KOH and a 1:1 H2O/EtOH solvent under reflux for 4 hours.
27 Unexpectedly, an 1H 
NMR spectrum from the 60 MHz NMR suggested that the product was 2-allyl-hexanoic 
acid 3, suggesting that the hydrolysis and decarboxylation occurred in tandem, so the 
decarboxylation step of the synthesis was skipped (Scheme 6). This caused issues in the 
esterification step later on in the synthesis, because the product was actually 
allylbutylmalonic acid 2. 
 
 
Scheme 6: Assumed tandem hydrolysis/decarboxylation of  
diethyl allylbutylmalonate (1) and subsequent reactions 
 
This was discovered when an 1H NMR of a product that was expected to be 2-allyl-1-




determined to actually be the diol shown in Figure 3, indicating that the decarboxylation 
did not actually occur in tandem with the hydrolysis earlier in the synthesis (Scheme 7). 
 
                     
Figure 2: 2-allyl-1-hexanol (4)  Figure 3: 2-allyl-1-butyl-1,3-propanediol 
 
  
Scheme 7: Actual hydrolysis of diethyl allylbutylmalonate (1)  
and subsequent reactions 
 
 The decarboxylation of 2 was conducted following a literature procedure in which 
2 was heated to 155°C for 4 hours, producing 2-allyl-hexanoic acid 3.26 The product of 
this reaction was verified by 1H NMR (Figure 12). 
Synthesis of 2cx-MMHP (6) 




aluminum hydride (LAH) reduction, esterification, and oxidation. The LAH reduction of 
3 was initially conducted following a literature procedure in which 1 equivalent of LAH 
was used and the reaction was set up at 0°C and stirred at room temperature overnight.28 
This reaction was deemed unsuccessful when a TLC of the crude product had the same Rf 
as the starting material. The reaction was modified based on a literature procedure in 
which 3 equivalents of LAH were used and the reaction was refluxed in dry diethyl 
ether.29 Due to a lack of dry diethyl ether, the reduction of 3 was conducted with 3 
equivalents of LAH in dry THF at 40°C (Scheme 8). One hour of heating successfully 
produced 2-allyl-1-hexanol 4. 
 
 
Scheme 8: LAH reduction of 2-allyl-hexanoic acid (3) 
 
The product was verified via 1H NMR (Figure 13). Figure 4 shows 4 with 1H NMR peaks 
labelled. The triplet at 0.87-0.91 ppm represents the three H7 protons, which are split by 
two neighboring protons. The multiplet at 1.29 ppm contains the six alkyl H6 protons and 
the alcohol proton. At 1.57-1.61 ppm is a multiplet that represents the proton on the chiral 
carbon, H5; it is split by six neighboring protons. The triplet at 2.09-2.14 ppm represents 
the two H4 protons, which are split by H5 and H1. A doublet of doublets at 3.54-3.56 ppm 




the two H2 protons; each is split by the H1 proton and the other H2 proton. The final 
multiplet at 5.77-5.86 ppm contains the single H1 proton, which is split by the two H4 
protons and each H2 proton separately.  
 
 
Figure 4: 2-allyl-1-hexanol (4) with 1H NMR peaks labelled 
 
 The esterification of 4 with phthalic anhydride was conducted in pyridine at reflux 
for 3 hours in accordance with the literature (Scheme 9).6 Mono(2-allylhexyl) phthalate 5 
was produced in 79% yield and verified by 1H NMR (Figure 14).  
 
 
Scheme 9: Esterification of 2-allyl-1-hexanol (4) with phthalic anhydride 
 
Figure 5 shows 5 with 1H NMR peaks labelled. Protons H10, H9, H7, H5, and H4 have 
chemical shifts and splitting patterns that are in agreement with the corresponding 
protons in 2-allyl-1-hexanol 4. A slight downfield shift is seen for protons H8 and H6 due 




1H NMR of 4 in the region of 7.5-8.5 ppm represent aromatic protons. The resolution is 
not high enough for the determination of splitting patterns and coupling constants, so the 
peaks were assigned based on predicted chemical shifts. The shifts calculated from a 
table in Pretsch were 8.24 ppm for H1, 8.21 ppm for H2, 7.73 ppm for the H3 meta to the 
ester, and 7.68 ppm for the H3 meta to the carboxylic acid.
31 The peaks were assigned 
accordingly; the peak at 7.57-7.62 ppm represents the two H3 protons, the peak at 7.70-
7.73 ppm represents H2, and the peak at 7.91-7.94 ppm represents H1. A carboxylic acid 
peak was not present in the 1H NMR; this could be due to hydrogen-deuterium exchange 
with the solvent, CDCl3, or the peak being very broad. 
 
 
Figure 5: Mono(2-allylhexyl) phthalate (5) with 1H NMR peaks labelled 
 
 The ruthenium-catalyzed oxidative cleavage of 5 was conducted following a 
literature procedure.30 By using 2.2 mol% of RuCl3, 4.1 equivalents NaIO4, and 2:2:3 
CCl4/CH3CN/H2O as solvent, 2cx-MMHP 6 was produced in 97% yield (Scheme 10). 
Purification of this product, however, proved difficult due to the fact that the aldehyde 
shown in Figure 6 is an intermediate in this reaction and was present in the crude product. 
The best separation by TLC was seen with a 9:1 CH2Cl2/MeOH solvent with a few drops 
of acetic acid. The Rf values of 2cx-MMHP (0.26) and 2COH-MMHP (0.24) were very 




acid in MeOH successfully removed the 2COH-MMHP. However, the residual acetic 
acid was difficult to remove, so an acetic acid peak is present in the 1H NMR (Figure 15) 
at 2.11 ppm. The overall yield of this synthesis was 14%. 
 
 
Scheme 10: Oxidative cleavage of mono(2-allylhexyl) phthalate (5) 
 
 
Figure 6: 2COH-MMHP 
 
2cx-MMHP 6 was verified via 1H NMR (Figure 15). Figure 7 shows 6 with 1H NMR 
peaks labelled. The peak at 2.11 ppm is acetic acid and the peak at 3.72 ppm is an 
unknown impurity. Protons H8, H7, and H2 have chemical shifts and splitting patterns that 
are in agreement with the corresponding protons in mono(2-allylhexyl) phthalate 5. The 
protons labeled H6 have a downfield shift (2.31-2.60 ppm) due to deshielding caused by 




clearly seen in this NMR: a unique peak is present for each proton. Some of the aromatic 
protons overlapping, so the peak at 7.56-7.67 ppm represents the three H3 protons. Lastly, 
a broad carboxylic acid peak is present at 7.90-9.58 ppm that encompasses both 
carboxylic acid protons, H1. 
 
 
Figure 7: 2cx-MMHP (6) with 1H NMR peaks labelled 
 
Malonic ester synthesis of 2-ethyl-5-hexenoic acid (10) 
 The synthesis of 2-ethyl-5-hexenoic acid 10 was analogous to the synthesis of 2-
allyl-hexanoic acid 3. However, prior to the malonate alkylation, the synthesis of 4-iodo-
1-butene 7 from 4-bromo-1-butene was necessary since 4-bromo-1-butene is not reactive 
enough, and 4-iodo-1-butene 7 is not commercially available. This substitution reaction 
was conducted with 1.67 equivalents of NaI in acetone at reflux for 1 hour in accordance 
with the literature procedure (Scheme 11).32 
 
 






The synthesis of 10 is shown in Scheme 12. Diethyl ethylmalonate was alkylated 
with 4-iodo-1-butene 7 yielding diethyl (3-butenyl)ethyl malonate 8. The subsequent 
hydrolysis produced (3-butenyl)ethylmalonic acid 9 in 24% yield; the product was 
verified by 1H NMR (Figure 16). (3-butenyl)ethylmalonic acid 9 then underwent 
decarboxylation, generating 2-ethyl-5-hexenoic acid 10, which was confirmed by 1H 




Scheme 12: Synthesis of 2-ethyl-5-hexenoic acid (10) 
 
Synthesis of mono(2-ethyl-5-hexenyl) phthalate (12) 
 Mono(2-ethyl-5-hexenyl) phthalate 12 was synthesized from 2-ethyl-5-hexenoic 
acid 10 by LAH reduction followed by esterification. The LAH reduction of 10 was 






Scheme 13: LAH reduction of 2-ethyl-5-hexenoic acid (10) 
 
2-Ethyl-5-hexen-1-ol 11 was produced, and its identity was verified via 1H NMR. Figure 
8 shows 11 with the 1H NMR peaks labelled. The triplet at 0.87-0.92 ppm corresponds to 
the three H6 protons, which are split by the two neighboring H5 protons. A multiplet at 
1.36-1.43 ppm represents the five alkyl H5 protons and the alcohol proton. The quartet at 
2.07-2.09 ppm corresponds to the two H4 protons split by three neighboring protons. At 
3.55-3.57 ppm is a doublet that contains the two H3 protons, which are split by the single 
neighboring H5 proton. The multiplet at 4.93-5.04 ppm represents the two H2 protons; 
each is split by H1 and the other H2 proton. Lastly, the multiplet at 5.77-5.86 ppm 










The esterification of 11 with phthalic anhydride followed the same procedure as 
the esterification of 2-ethyl-5-hexen-1-ol 11 (Scheme 14). Mono(2-ethyl-5-hexenyl) 
phthalate 12 was produced in 86% yield; the product was confirmed by 1H NMR (Figure 
19). The overall yield of this synthesis was 34%. 
 
 
Scheme 14: Esterification of 2-ethyl-5-hexen-1-ol (11) with phthalic anhydride 
 
Figure 9 shows 12 with the 1H NMR peaks labelled. Peaks at 1.19-1.24 ppm and 3.48-
3.51 ppm are impurities. Protons H12, H8, H5, and H4 have chemical shifts and splitting 
patterns that are in agreement with the corresponding protons in 2-ethyl-5-hexen-1-ol 11. 
Protons H10 and H9 are shifted slightly downfield (1.41-1.47 and 1.71-1.75 ppm, 
respectivity) due to deshielding due to their proximity to the ester, while protons H6 are 
shifted dramatically downfield (4.25-4.27 ppm) due to the neighboring ester. The 
aromatic protons were assigned based on the predicted shifts calculated from a table in 
Pretsch for mono(2-allylhexyl) phthalate 5, so the peak at 7.59 corresponds to the two H3 
protons, the peak at 7.68-7.70 ppm corresponds to the single H2 proton, and the peak at 
7.90-7.92 ppm corresponds to the single H1 proton.
31 A carboxylic acid peak was not 
present in the 1H NMR; this could be due to hydrogen-deuterium exchange with the 










III. Conclusions and Future Work 
Racemic 2cx-MMHP 6 and mono(2-ethyl-5-hexenyl) phthalate 12 were 
successfully synthesized. Both syntheses involved malonic ester syntheses, LAH 
reduction, and esterification; however, the synthesis of 6 involved an additional 
oxidation. Further work is necessary to produce the three other prevalent oxidative 
metabolites of DEHP: 5oxoMEHP, 5OH-MEHP, and 5cx-MEPP. 
Synthesis of 5oxo-MEHP, 5OH-MEHP, and 5cx-MEPP 
 A proposed synthesis of 5oxo-MEHP, 5OH-MEHP, and 5cx-MEPP from 12 is 
shown in Scheme 15.  
 
 





5oxo-MEHP can be produced by a palladium-catalyzed Wacker-Tsuji oxidation of 12, 
which oxidizes the alkene to a ketone.6 A subsequent sodium borohydride (NaBH4) 
reduction of 5oxo-MEHP would produce 5OH-MEHP by reducing the ketone to an 
alcohol.6 The synthesis of 5cx-MEPP involves two steps. The first is a hydroboration-
oxidation reaction, which adds water across the alkene in an anti-Markovnikov fashion.33 
The second is the oxidation of the resulting alcohol to a carboxylic acid (i), which can be 
achieved by a variety of methods. One is oxidation utilizing TEMPO and 
(diacetoxyiodo)benzene (PhI(OAc)2).
34 Another is the Jones oxidation which uses CrO3 
and diluted H2SO4 .
6 Once racemic 5oxoMEHP, 5OH-MEHP, and 5cx-MEPP are 
synthesized, a resolution step will be incorporated into the syntheses so both enantiomers 
of each metabolite can be synthesized. 
Enzymatic resolution of alcohols 
 One possible resolution method is the enzymatic resolution of the primary 
alcohols, 2-allyl-1-hexanol 4 and 2-ethyl-5-hexen-1-ol 11. This resolution would utilize 
the lipase Burkholderia cepacia (PSBC) to acylate the (S) enantiomer of the alcohol with 
vinyl acetate. The (R) alcohol and (S) acetate will then be separated by column 
chromatography, and both enantiomers of the alcohol would be obtained upon hydrolysis 
of the (S) acetate.35 The proposed resolution of 11 is shown in Scheme 16. 
 




Resolved 2-allyl-1-hexanol 4 could be used to synthesize enantiomerically pure 2cx-
MMHP, and resolved 2-ethyl-5-hexen-1-ol 11 could be used to synthesize 





Suppliers and purities of all chemicals are listed in Appendix B. Anhydrous 
tetrahydrofuran (THF) was dispensed from an MBraun Solvent Purification System. All 
other reagents were used as received. Column chromatography was conducted on a 
Biotage Isolera One flash system. Spectra were obtained on either a Varian 60 MHz 
NMR or a Bruker 300 MHz NMR in CDCl3 with TMS as an internal standard. 
Diethyl allylbutylmalonate (1). A round-bottom flask and magnetic stir bar were dried 
in the oven and cooled under nitrogen. NaH (60% dispersion in mineral oil, 0.3876 g, 
9.69 mmol) was added, and the flask was fitted with a septum and put under nitrogen. 
After the addition of THF (30 mL), the flask was placed in an ice bath and allowed to 
cool for 10 minutes. Diethyl allylmalonate (1.55 mL, 1.56 g, 7.81 mmol) was added, and 
the reaction was allowed to stir at 0°C for 30 minutes. The reaction mixture turned from 
light yellow to a darker yellow. After the addition of 1-iodobutane (1.33 mL, 2.15 g, 11.7 
mmol), the reaction proceeded for 21 hours at room temperature and turned an even 
darker yellow. The reaction mixture was quenched with aqueous saturated NH4Cl (15 
mL) and extracted with Et2O (3 x 15 mL). The organic layers were combined, dried over 
MgSO4, and concentrated under vacuum. The product was purified by flash column 
chromatography in hexanes/ethyl acetate with 6% ethyl acetate for 1 column volume 
(CV), followed by a gradient of 6-50% ethyl acetate for 10 CV, followed by 50% ethyl 
acetate for 2 CV. Diethyl allylbutylmalonate 1 (1.44 g, 5.70 mmol, 73%) was obtained as 
a yellow liquid. 1H NMR (60 MHz): δ = 0.77-2.00 (m, 15H, H1), 2.59-2.71 (d, 2H, H2), 





Allylbutylmalonic acid (2). Diethyl allylbutylmalonate 1 (3.72 g, 14.5 mmol), KOH 
(2.47 g, 44.0 mmol), ethanol (90 mL), and H2O (30 mL) were combined and heated to 
reflux for 4 hours. After cooling, most of the solvent was evaporated under vacuum. H2O 
(50 mL) was added, and the resulting solution was acidified to pH 1 with 6M HCl, 
causing the formation of a white precipitate. The mixture was extracted with Et2O (3 x 50 
mL) and washed with brine (50 mL). The organic layers were combined, dried over 
MgSO4, and concentrated under vacuum. Crude allylbutylmalonic acid 2 (2.40 g) was 
obtained as a yellow liquid. The product was used without further purification. NMR data 
is unavailable. 
2-Allyl-hexanoic acid (3). Crude allylbutylmalonic acid 2 (2.40 g) was heated to 155°C 
for 4 hours. The resulting brown liquid was purified by flash column chromatography in 
hexanes/ethyl acetate with 6% ethyl acetate for 1 CV, followed by a gradient of 6-50% 
ethyl acetate for 10 CV, followed by 50% ethyl acetate for 2 CV. 2-Allyl-hexanoic acid 3 
(0.32 g, 2.1 mmol) was obtained as a colorless liquid. 1H NMR (60 MHz): δ = 0.57-1.06 
(m, 9H, H1), 1.98-2.06 (m, 3H, H2), 4.61-4.86 (m, 2H, H3), 5.20-5.82 (m, 1H, H4), 9.72 
(s, 1H, H5) ppm (Figure 12). 
2-Allyl-1-hexanol (4). A round-bottom flask, magnetic stir bar, and condenser were dried 
in the oven, cooled under nitrogen, and placed in an ice bath. Crude 2-allyl-hexanoic acid 
3 (4.42 g) and THF (50 mL) were added, followed by the slow addition of a 1M LAH 
solution (50 mL, 1.9 g, 50 mmol). The reaction mixture was heated to 40°C for 1 hour. 
After cooling, the flask was placed in an ice bath. Separate portions of H2O (1.9 mL), 5M 
NaOH (1.9 mL), and H2O (5.7 mL) were slowly added to quench the reaction, resulting 




funnel and rinsed with H2O (20 mL) and Et2O (20 mL). H2O (20 mL) was added to the 
filtrate, and the resulting solution was extracted with Et2O (3 x 30 mL). The organic 
layers were combined, dried over MgSO4, and concentrated under vacuum. The product 
was purified by flash column chromatography in hexanes/ethyl acetate with 12% ethyl 
acetate for 1 CV, followed by a gradient of 12-100% ethyl acetate for 10 CV, followed by 
100% ethyl acetate for 2 CV. 2-Allyl-1-hexanol 4 (0.63 g, 4.4 mmol) was obtained as a 
colorless liquid. 1H NMR (300 MHz): δ = 0.87-0.91 (t, 3H, H7), 1.29 (m, 7H, H6), 1.57-
1.61 (m, 1H, H5), 2.09-2.14 (t, 2H, H4), 3.54-3.56 (dd, 2H, H3) , 5.00-5.08 (m, 2H, H2), 
5.77-5.86 (m, 1H, H1) ppm (Figure 13). 
Mono(2-allylhexyl) phthalate (5). 2-allyl-1-hexanol 4 (0.28 g, 1.9 mmol), phthalic 
anhydride (0.30 g, 2.1 mmol), and pyridine (0.2 mL) were combined and heated to reflux 
for 3 hours. The reaction mixture was then diluted with H2O (15 mL) and extracted with 
Et2O (3 x 15 mL). The organic layers were combined, washed with 3M HCl (2 x 15 mL), 
dried over MgSO4, and concentrated under vacuum. Crude mono(2-allylhexyl) phthalate 
5 (0.45 g, 1.5 mmol, 79%) was obtained as a colorless liquid. The product was used 
without further purification. 1H NMR (300 MHz): δ = 0.85-0.89 (t, 3H, H10), 1.28-1.36 
(m, 6H, H9), 1.82-1.90 (m, 1H, H8), 2.14-2.18 (t, 2H, H7), 4.24-4.26 (dd, 2H, H6), 5.01-
5.07 (m, 2H, H5), 5.72-5.85 (m, 1H, H4), 7.57-7.62 (m, 2H, H3), 7.70-7.73 (m, 1H, H2), 
7.91-7.94 (m, 1H, H1) ppm (Figure 14). 
2cx-MMHP (6). Mono(2-allylhexyl) phthalate 5 (0.47 g, 1.6 mmol), RuCl3 (0.0073 g, 
0.035 mmol), NaIO4 (1.41 g, 6.6 mmol), carbon tetrachloride (4 mL), acetonitrile (4 mL), 
and H2O (6 mL) were combined in a round-bottom flask. The flask was sealed with a 




(15 mL) and H2O (40 mL), the reaction mixture was extracted with dichloromethane (3 x 
15 mL). The organic layers were combined, dried over MgSO4, and concentrated under 
vacuum to obtain crude 2cx-MMHP 6 as a black liquid. The product was purified by 
flash column chromatography in dichloromethane/methanol plus 0.5% acetic acid with 
2% methanol for 1 CV, followed by a gradient of 2-20% methanol for 10 CV, followed 
by 20% methanol for 2 CV. 2cx-MMHP 6 (0.30 g, 0.97 mmol, 97%) was obtained as a 
colorless liquid. 1H NMR (300 MHz): δ = 0.87-0.91 (t, 3H, H8), 1.32-1.40 (m, 6H, H7), 
2.31-2.60 (m, 3H, H6), 4.18-4.45 (dd, dd, 2H, H4 and H5), 7.56-7.67 (m, 3H, H3), 7.90-
7.92 (m, 1H, H2), 9.58 (s, 2H, H1) ppm (Figure 15). 
4-Iodo-1-butene (7). Due to the light sensitivity of both 4-bromo-1-butene and 4-iodo-1-
butene, the reaction and workup procedure were done in low light conditions. 4-Bromo-
1-butene (6.1 mL, 8.1 g, 60 mmol), NaI (14.99 g, 100 mmol), and acetone (60 mL) were 
combined and heated to reflux for 1 hour. The condenser was removed, a fractional 
distillation apparatus was assembled on the flask, and most of the acetone was distilled 
off. After the addition of H2O (30 mL), the mixture was extracted with Et2O (3 x 25 mL). 
The organic layers were washed with H2O (25 mL), aqueous saturated NaSO3 (25 mL), 
and brine (25 mL). The Et2O layer was then dried over MgSO4, and concentrated under 
vacuum to obtain crude 4-iodo-1-butene (7.36 g) as a yellow liquid. The product was 
used without further purification. NMR data is unavailable. 
Diethyl (3-butenyl)ethyl malonate (8). A round-bottom flask and magnetic stir bar were 
dried in the oven and cooled under nitrogen. NaH (60% dispersion in mineral oil, 1.30 g, 
32.5 mmol) was added, and the flask was fitted with a septum, wrapped in aluminum foil, 




bath and allowed to cool for 10 minutes. Diethyl ethylmalonate (5.0 mL, 5.0 g, 26.6 
mmol) was added, and the reaction was allowed to stir at 0°C for 30 minutes. The 
reaction mixture turned from light yellow to a darker yellow. After the addition of a 
solution of crude 4-iodo-1-butene 7 (7.36 g) in THF (40 mL), the reaction was stirred for 
17 hours at room temperature and turned an even darker yellow. The reaction mixture 
was quenched with aqueous saturated NH4Cl (60 mL) and extracted with Et2O (4 x 30 
mL). The organic layers were combined, dried over MgSO4, and concentrated under 
vacuum. Crude diethyl (3-butenyl)ethyl malonate 8 (8.93 g) was obtained as a yellow 
liquid. The product was used without further purification. NMR data is unavailable. 
(3-Butenyl)ethylmalonic acid (9). Crude diethyl (3-butenyl)ethyl malonate 8 (1.11 g, 
4.58 mmol), KOH (1.33 g, 23.7 mmol), ethanol (15 mL), and H2O (15 mL) were 
combined and heated to reflux for 5 hours. After cooling, most of the solvent was 
evaporated under vacuum. H2O (15 mL) was added, and the resulting solution was 
acidified to pH 1 with 6M HCl, causing the formation of a white precipitate. The mixture 
was extracted with Et2O (3 x 10 mL) and washed with brine (15 mL). The organic layers 
were combined, dried over MgSO4, and concentrated under vacuum. The product was 
purified by flash column chromatography in hexanes/ethyl acetate with 12% ethyl acetate 
for 1 CV, followed by a gradient of 12-100% ethyl acetate for 10 CV, followed by 100% 
ethyl acetate for 2 CV. (3-Butenyl)ethylmalonic acid 9 (0.20 g, 1.1 mmol, 24%) was 
obtained as a colorless liquid. 1H NMR (60 MHz): δ = 0.80-1.04 (t, 3H, H1), 2.04 (m, 6H, 
H2), 4.87-5.16 (m, 2H, H3), 5.59-5.74 (m, 1H, H4), 9.65 (s, 2H, H5) ppm (Figure 16). 
2-Ethyl-5-hexenoic acid (10). Crude (3-butenyl)ethylmalonic acid 9  (0.85 g) was heated 




brown liquid. The product was used without further purification. 1H NMR (60 MHz): δ = 
0.83-1.06 (t, 3H, H1), 1.41-2.47 (m, 7H, H2), 4.89-5.16 (m, 2H, H3), 5.52-6.17 (m, 1H, 
H4), 9.61 (s, 1H, H5) ppm (Figure 17). 
2-Ethyl-5-hexen-1-ol (11). A round-bottom flask, magnetic stir bar, and condenser were 
dried in the oven, cooled under nitrogen, and placed in an ice bath. Crude 2-ethyl-5-
hexenoic acid 10 (1.69 g) and THF (50 mL) were added, followed by the slow addition of 
a 1M LAH solution (35 mL, 1.4 g, 37 mmol). The reaction mixture was heated to 40°C 
for 1 hour. After cooling, the flask was placed in an ice bath. Separate portions of H2O 
(1.4 mL), 5M NaOH (1.4 mL), and H2O (4.2 mL) were slowly added to quench the 
reaction, resulting in the formation of a white solid. The resulting mixture was filtered 
through a fritted filter funnel and rinsed with H2O (30 mL) and Et2O (15 mL). The filtrate 
was extracted with Et2O (3 x 20 mL). The organic layers were combined, dried over 
MgSO4, and concentrated under vacuum. The product was purified by flash column 
chromatography in hexanes/ethyl acetate with 12% ethyl acetate for 1 CV, followed by a 
gradient of 12-100% ethyl acetate for 10 CV, followed by 100% ethyl acetate for 2 CV. 
2-Ethyl-5-hexen-1-ol 11 (0.34 g, 2.7 mmol) was obtained as a colorless liquid. 1H NMR 
(300 MHz): δ = 0.87-0.92 (t, 3H, H6), 1.36-1.43 (m, 6H, H5), 2.07-2.09 (q, 2H, H4), 3.55-
3.57 (d, 2H, H3), 4.93-5.04 (m, 2H, H2), 5.77-5.86 (m, 1H, H1) ppm (Figure 18). 
Mono(2-ethyl-5-hexenyl) phthalate (12). 2-ethyl-5-hexen-1-ol 11 (1.38 g, 10.8 mmol), 
phthalic anhydride (1.59 g, 10.7 mmol), and pyridine (1.1 mL) were combined and heated 
to reflux for 3 hours. The reaction mixture was then diluted with H2O (25 mL) and 
extracted with Et2O (4 x 25 mL). The organic layers were combined, washed with 3M 




ethyl-5-hexenyl) phthalate 12 (2.57 g, 9.3 mmol, 86%) was obtained as a colorless liquid. 
1H NMR (300 MHz): δ = 0.89-0.94 (t, 3H, H12), 1.41-1.47 (m, 4H, H10), 1.71-1.75 (m, 
1H, H9), 2.08-2.11 (m, 2H, H8), 4.25-4.27 (d, 2H, H6), 4.91-5.03 (m, 2H, H5), 5.77-5.80 
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Appendix A: NMR Spectra 






















































Appendix B: Materials 
Reagent Supplier Purity/Grade 
1-iodobutane Thermo Fisher Scientific 
98%, stabilized over 
copper 
4-bromo-1-butene Tokyo Chemical Industry >97.0% 
Acetic acid Fisher Scientific Certified ACS Plus 
Acetone Fisher Scientific HPLC grade 
Acetonitrile (CH3CN) Fisher Scientific HPLC grade 
Ammonium chloride (NH4Cl) J.T. Baker 99.5% 
Carbon tetrachloride (CCl4) Thermo Fisher Scientific 99% 
Chloroform-d (CDCl3) Acros Organics 
99.8+ atom % D, contains 
0.03 v/v% TMS 
Dichloromethane (CH2Cl2) Fisher Scientific Certified ACS 
Diethyl allylmalonate Alfa Aesar 97% 
Diethyl ethylmalonate Acros Organics 99% 
Diethyl ether (Et2O) Fisher Scientific Laboratory grade 
Ethanol (EtOH) Fisher Scientific 95% 
Ethyl acetate Fisher Scientific Optima 
Hexanes Fisher Scientific Optima 
Hydrochloric acid (HCl) Fisher Scientific Certified ACS Plus 
Lithium aluminum hydride solution Sigma-Aldrich 1M in THF 
Magnesium sulfate (MgSO4) Fisher Scientific 
Powder certified, 
anhydrous 
Methanol (MeOH) Fisher Scientific HPLC grade 
Nitrogen (N2) Airgas Industrial grade 
Phthalic anhydride Thermo Fisher Scientific 99% 
Potassium hydroxide (KOH) Thermo Fisher Scientific Certified ACS 
Pyridine Acros Organics 99.5% 
Ruthenium(III) chloride (RuCl3) Sigma-Aldrich 99.98% trace metals basis 
Sodium chloride (NaCl) Sigma-Aldrich Certified ACS 
Sodium hydride (NaH) Sigma-Aldrich 
60% dispersion in 
mineral oil 
Sodium hydroxide (NaOH) Fisher Scientific Certified ACS 
Sodium iodide (NaI) Thermo Fisher Scientific Certified 
Sodium periodate (NaIO4) Fisher Scientific 99.8% 
Sodium sulfite (NaSO3) Sigma-Aldrich Certified ACS 
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